Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-044013
Date:2022-07-29
Issuer: AMNEAL PHARMACEUTICALS, INC. (AMRX)
Original Submission Date:

Reporting Person:

AUTOR DEBORAH M.
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD BRIDGEWATER, NJ 08807

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2022-07-29 deemed execution date A 54,949 (a) class a common stock 54,949 $0.00 54,949 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of the issuer's class a common stock.
f2 restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant.
WhaleWisdom Logo

Elevate your investments